EGI
TMDX icon

EAM Global Investors’s Transmedics TMDX Stock Holding History

EAM Global Investors’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-26,036
Closed -$3.49M – 71
2025
Q2 		$3.49M Buy
+26,036
New +$2.86M 0.9% 70
2024
Q4 		– Sell
-35,905
Closed -$5.64M – 160
2024
Q3 		$5.64M Buy
35,905
+174
+0.5% +$26.8K 1.14% 28
2024
Q2 		$5.38M Buy
+35,731
New +$4.29M 1.21% 26
2023
Q3 		– Sell
-61,743
Closed -$5.19M – 132
2023
Q2 		$5.19M Sell
61,743
-8,034
-12% -$615K 1.52% 11
2023
Q1 		$5.28M Sell
69,777
-15,254
-18% -$1.05M 1.48% 15
2022
Q4 		$5.25M Buy
85,031
+19,342
+29% +$1.03M 1.36% 5
2022
Q3 		$2.74M Sell
65,689
-22,257
-25% -$968K 0.73% 30
2022
Q2 		$2.77M Buy
+87,946
New +$2.35M 0.68% 35

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

EAM Global Investors's TMDX Position: Q3 2025 in Review

EAM Global Investors sold out of Transmedics (TMDX) in Q3 2025, closing a stake of 26,036 shares — an estimated $3.49M sold.

EAM Global Investors first reported a position in TMDX in Q2 2022 and held it in 8 quarters. The position peaked at $5.64M in Q3 2024. 388 funds tracked by Wall St. Rank hold TMDX as of Q3 2025.

  • EAM Global Investors reported no remaining Transmedics position as of Q3 2025 after selling out during the quarter.
  • EAM Global Investors sold 26,036 Transmedics shares in Q3 2025, an estimated $3.49M.
  • EAM Global Investors first reported a position in Transmedics in Q2 2022 and held it in 8 quarters.
  • EAM Global Investors's Transmedics position peaked at $5.64M in Q3 2024.
  • 388 funds tracked by Wall St. Rank held Transmedics as of Q3 2025.

Based on EAM Global Investors's 13F filing for Q3 2025, filed 14 Nov 2025.